Forbion et al. sell Santaris Pharma to Roche for $450m
An investor consortium comprising Sunstone Capital, Gilde Healthcare and Forbion Capital among others has sold Danish biopharma business Santaris to Swiss healthcare firm Roche for $450m.
More on Exits
Inflexion sells The Goat Agency to trade, nets 80% IRR
GP sells minority stake in UK-based social media marketing agency after two year investment period
Lenders sway fate of auctions in volatile LBO market
Vendors increasingly sounding out lenders before bidders to navigate uncertain M&A landscape
Nordic picks Jefferies for upcoming Sunrise Medical auction
German wheelchair specialist was acquired in 2015 and moved to a continuation fund in 2018
GP Profile: Inspirit anticipates carve-outs uptick with fundraising on the horizon by year-end
Complex carve-outs specialist could raise around GBP 75m for its second fund with debut vehicle around 70% deployed
Latest News
GP Profile: BGF to deploy GBP 500m-plus per year for minority growth deals with entrepreneurs
UK and Ireland-based growth investor remains committed to filling a market gap for founders who want flexibility and control
European sponsors sidestep panic, concede gloom over bank woes
Fallout from Credit Suisse collapse adds to slew of macroeconomic challenges for PE dealmaking and fundraising
Inflexion sells The Goat Agency to trade, nets 80% IRR
GP sells minority stake in UK-based social media marketing agency after two year investment period
Synova kicks off new fund deployment with Learnlight acquisition
Investment in Spanish edtech platform is the first from GBP 875m vehicle raised in three months last year